Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 0.65 is 73% below its 5-year average of 2.41, near the low end of its 5-year range (0.65–6.06).
As of the fiscal period ended Tuesday, March 31, 2026. 29.77% below its 12-month average of 0.92.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-03-31): 0.65.
QUICK RATIO (ACID-TEST)
0.65
QUICK RATIO (ACID-TEST) AVG TTM
0.92
QUICK RATIO (ACID-TEST) AVG 3Y
2.55
QUICK RATIO (ACID-TEST) AVG 5Y
2.41
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-29.77%
CURRENT VS 3Y AVG
-74.63%
CURRENT VS 5Y AVG
-73.12%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.19
median of 736 covered companies
CURRENT VS SECTOR MEDIAN
-79.73%
vs the sector median at left
BGM Group Ltd.
Market Cap
$111.52M
Quick Ratio (Acid-Test)
0.65
TTM Avg
0.92
3Y Avg
2.55
5Y Avg
2.41
Market Cap
$110.75M
Quick Ratio (Acid-Test)
4.53
TTM Avg
4.41
3Y Avg
4.05
5Y Avg
4.51
Market Cap
$112.03M
Quick Ratio (Acid-Test)
12.63
TTM Avg
12.83
3Y Avg
15.22
5Y Avg
15.22
Market Cap
$110.11M
Quick Ratio (Acid-Test)
1.98
TTM Avg
1.40
3Y Avg
1.60
5Y Avg
1.70
Market Cap
$112.48M
Quick Ratio (Acid-Test)
11.47
TTM Avg
9.04
3Y Avg
10.96
5Y Avg
10.73
Market Cap
$109.37M
Quick Ratio (Acid-Test)
0.63
TTM Avg
0.47
3Y Avg
0.75
5Y Avg
1.22
Market Cap
$108.87M
Quick Ratio (Acid-Test)
7.28
TTM Avg
6.67
3Y Avg
7.13
5Y Avg
10.02
Market Cap
$114.81M
Quick Ratio (Acid-Test)
1.31
TTM Avg
1.18
3Y Avg
1.49
5Y Avg
3.22
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BGM Group Ltd. (BGM) | $111.52M | 0.65 | 0.92 | 2.55 | 2.41 |
| Apyx Medical Corporation (APYX)vs › | $110.75M | 4.53 | 4.41 | 4.05 | 4.51 |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $112.03M | 12.63 | 12.83 | 15.22 | 15.22 |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $110.11M | 1.98 | 1.40 | 1.60 | 1.70 |
| MaxCyte, Inc. (MXCT)vs › | $112.48M | 11.47 | 9.04 | 10.96 | 10.73 |
| Outlook Therapeutics, Inc. (OTLK)vs › | $109.37M | 0.63 | 0.47 | 0.75 | 1.22 |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $108.87M | 7.28 | 6.67 | 7.13 | 10.02 |
| Immunic, Inc. (IMUX)vs › | $108.82M | 5.05 | 1.26 | 3.46 | 6.50 |
| Lucid Diagnostics Inc. (LUCD)vs › | $114.81M | 1.31 | 1.18 | 1.49 | 3.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $107.65M | 5.71 | 10.50 | 6.63 | 5.88 |
Quick Ratio
0.65
Excludes inventory
Current Ratio
1.25
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-03-31 | 0.65 |
| 2025-09-30 | 0.67 |
| 2025-03-31 | 1.45 |
| 2024-09-30 | 2.82 |
| 2024-03-31 | 6.06 |
| 2023-09-30 | 4.43 |
| 2023-03-31 | 1.76 |
| 2022-09-30 | 2.30 |
| 2022-03-31 | 1.33 |
| 2021-09-30 | 1.53 |
| 2021-03-31 | 3.45 |
| 2020-09-30 | 1.39 |
| 2020-03-31 | 1.53 |
| 2019-09-30 | 1.07 |
| 2019-03-31 | 1.09 |
| 2018-09-30 | 0.88 |
